Casting a shadow on liver X receptor-mediated atheroprotection: Is LXRβ to blame?

Journal of Internal Medicine

Volumn 272, Issue 5, 2012, Pages 449-451

  Degirolamo, C ^a,b   Moschetta, A ^a,b  

^a The Department of Translational Pharmacology   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; BILE ACID; CHOLESTEROL; EZETIMIBE; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CORONARY RISK; DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; INTESTINAL ABSORPTION; LIPOPROTEINS; LIVER; MALE; ORPHAN NUCLEAR RECEPTORS;

EID: 84867918356     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02561.x     Document Type: Note

References (19)

1. Repa JJ, Mangelsdorf DJ. The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 2002; 8: 1243-8.
2. Peet DJ, Turley SD, Ma W et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93: 693-704.
3. Alberti S, Schuster G, Parini P et al. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 2001; 107: 565-73.
4. Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003; 17: 985-93.
5. Schultz JR, Tu H, Luk A et al. Role of LXRs in control of lipogenesis. Genes Dev 2000; 14: 2831-8.
6. Bischoff ED, Daige CL, Petrowski M et al. Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. J Lipid Res 2010; 51: 900-6.
7. Korach-Andre M, Parini P, Larsson L, Arner A, Steffensen KR, Gustafsson JA. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Am J Physiol Endocrinol Metab 2010; 298: E167-78.
8. Quinet EM, Savio DA, Halpern AR et al. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting. Mol Pharmacol 2006; 70: 1340-9.
9. Lund EG, Peterson LB, Adams AD et al. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Biochem Pharmacol 2006; 71: 453-63.
10. Bradley MN, Hong C, Chen M et al. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J Clin Invest 2007; 117: 2337-46.
11. Lo Sasso G, Murzilli S, Salvatore L et al. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 2010; 12: 187-93.
12. Tangirala RK, Bischoff ED, Joseph SB et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA 2002; 99: 11896-901.
13. Levin N, Bischoff ED, Daige CL et al. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 2005; 25: 135-42.
14. Naik SU, Wang X, Da Silva JS et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006; 113: 90-7.
15. Yu L, Gupta S, Xu F et al. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 2005; 280: 8742-7.
16. Davis HR Jr, Hoos LM, Tetzloff G et al. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice. Arterioscler Thromb Vasc Biol 2007; 27: 841-9.
17. Kastelein JJ, Akdim F, Stroes ES et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43.
18. Hu X, Steffensen KR, Jiang ZY et al. LXRbeta activation increases intestinal cholesterol absorption leading to an atherogenic lipoprotein profile. J Intern Med 2012. doi: 10.1111/j.1365-2796.2012.02529.
19. Hong C, Bradley MN, Rong X et al. LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice. J Lipid Res 2012; 53: 1126-33.